Following reports of a rare blood clot reaction, the Centers for Disease Control and Prevention recommended a pause in the use of the Johnson & Johnson vaccine out of “an abundance of caution.”
Following reports of a rare blood clot reaction, the Centers for Disease Control and Prevention recommended a pause in the use of the Johnson & Johnson vaccine out of “an abundance of caution.”